Fundraising FoxmediQuo
3 known investors
Find your way into mediQuo
Sign up to see every warm intro you have to mediQuo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the mediQuo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
mediQuo operates an omnichannel telemedicine platform with its own medical team of over 300 professionals across 22+ specialties, offering patients chat, calls, scheduled and on-demand video consultations, online appointments, e-prescriptions, and AI-generated medical reports. It sells white-label, integrable software and provides specialized digital clinics and employee health benefit plans, with GDPR alignment and ISO/IEC 27001 certification.
Investors · 3
How we know: Capital Cell's portfolio page · Not right? Tell us
How we know: Dozen Investments's portfolio page · Not right? Tell us
How we know: Target Global's portfolio page · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeed RoundNov 2018Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does mediQuo do?
- mediQuo operates an omnichannel telemedicine platform with its own medical team of over 300 professionals across 22+ specialties, offering patients chat, calls, scheduled and on-demand video consultations, online appointments, e-prescriptions, and AI-generated medical reports. It sells white-label, integrable software and provides specialized digital clinics and employee health benefit plans, with GDPR alignment and ISO/IEC 27001 certification.
- Who are mediQuo's investors?
- mediQuo's investors include Capital Cell, Dozen Investments, Target Global.